QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)

Enanta Pharmaceuticals (ENTA) News Today

$13.46
+0.95 (+7.59%)
(As of 02/23/2024 ET)
SourceHeadline
marketbeat.com logoAcadian Asset Management LLC Buys 448,201 Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)
marketbeat.com - February 23 at 7:35 AM
marketbeat.com logoShort Interest in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Rises By 15.7%
marketbeat.com - February 16 at 8:19 PM
finance.yahoo.com logoEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
finance.yahoo.com - February 12 at 8:51 AM
markets.businessinsider.com logoOppenheimer Keeps Their Hold Rating on Enanta Pharmaceuticals (ENTA)
markets.businessinsider.com - February 9 at 2:34 PM
markets.businessinsider.com logoMaintaining Hold on Enanta Pharmaceuticals Amid Near-Term Challenges and Pipeline Potential
markets.businessinsider.com - February 9 at 9:34 AM
marketbeat.com logoBank of New York Mellon Corp Has $1.21 Million Position in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)
marketbeat.com - February 9 at 4:22 AM
finance.yahoo.com logoQ1 2024 Enanta Pharmaceuticals Inc Earnings Call
finance.yahoo.com - February 8 at 9:43 AM
finance.yahoo.com logoEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript
finance.yahoo.com - February 8 at 9:43 AM
marketbeat.com logoLeerink Partnrs Comments on Enanta Pharmaceuticals, Inc.'s Q2 2024 Earnings (NASDAQ:ENTA)
marketbeat.com - February 8 at 7:46 AM
benzinga.com logoRecap: Enanta Pharma Q1 Earnings
benzinga.com - February 7 at 9:01 PM
finance.yahoo.com logoEnanta Pharmaceuticals Inc (ENTA) Reports Fiscal Q1 2024 Results: Royalty Revenue Declines Amid ...
finance.yahoo.com - February 7 at 9:01 PM
finance.yahoo.com logoEnanta Pharmaceuticals (ENTA) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - February 7 at 9:01 PM
businesswire.com logoEnanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
businesswire.com - February 7 at 4:09 PM
marketbeat.com logoLeerink Partnrs Weighs in on Enanta Pharmaceuticals, Inc.'s Q1 2024 Earnings (NASDAQ:ENTA)
marketbeat.com - February 7 at 8:06 AM
benzinga.com logoEarnings Preview For Enanta Pharma
benzinga.com - February 6 at 9:13 PM
finance.yahoo.com logoEnanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
finance.yahoo.com - February 6 at 8:25 AM
marketbeat.com logoEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Recommendation of "Hold" by Brokerages
marketbeat.com - February 5 at 1:42 AM
finance.yahoo.com logoEnanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
finance.yahoo.com - January 31 at 8:25 AM
marketbeat.com logoEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Shares Purchased by Assenagon Asset Management S.A.
marketbeat.com - January 30 at 5:59 AM
marketbeat.com logoEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Sees Significant Decline in Short Interest
marketbeat.com - January 16 at 11:37 AM
marketbeat.com logoEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Average Recommendation of "Hold" from Analysts
marketbeat.com - January 11 at 2:36 AM
markets.businessinsider.com logoBuy Rating on Enanta Pharmaceuticals Amidst Promising RSV Program Developments and Strategic Expansion into CSU Market
markets.businessinsider.com - January 5 at 8:27 AM
finance.yahoo.com logoStrength Seen in Enanta Pharmaceuticals (ENTA): Can Its 13.8% Jump Turn into More Strength?
finance.yahoo.com - January 5 at 8:27 AM
finance.yahoo.com logoEnanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 10:07 AM
marketbeat.com logoEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Short Interest Update
marketbeat.com - January 1 at 12:20 AM
marketbeat.com logoEnanta Pharmaceuticals (NASDAQ:ENTA) Upgraded at StockNews.com
marketbeat.com - December 19 at 10:17 PM
finance.yahoo.com logoInsider Sell Alert: Director Terry Vance Sells 15,295 Shares of Enanta Pharmaceuticals Inc (ENTA)
finance.yahoo.com - December 16 at 8:23 AM
marketbeat.com logoTerry Vance Sells 15,295 Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Stock
marketbeat.com - December 15 at 9:23 PM
finance.yahoo.com logoWall Street Analysts Predict a 108.12% Upside in Enanta Pharmaceuticals (ENTA): Here's What You Should Know
finance.yahoo.com - December 13 at 3:47 PM
finance.yahoo.com logoWall Street Analysts Predict a 108.12% Upside in Enanta Pharmaceuticals (ENTA): Here's What You Should Know
finance.yahoo.com - December 13 at 3:47 PM
finance.yahoo.com logoHow Much Upside is Left in Enanta Pharmaceuticals (ENTA)? Wall Street Analysts Think 88.23%
finance.yahoo.com - November 27 at 4:46 PM
benzinga.com logoEnanta Pharma Stock (NASDAQ:ENTA) Insider Trades
benzinga.com - November 23 at 3:43 PM
benzinga.com logoEnanta Pharma Stock (NASDAQ:ENTA) Earnings Dates and Earning Calls
benzinga.com - November 22 at 10:58 PM
finance.yahoo.com logoEnanta Pharmaceuticals to Participate at Evercore ISI HealthCONx Conference
finance.yahoo.com - November 22 at 7:57 AM
marketwatch.com logoEnanta Pharmaceuticals Shares Rise 21% After Slashing Spending Guidance
marketwatch.com - November 21 at 3:22 PM
markets.businessinsider.com logoWhat 5 Analyst Ratings Have To Say About Enanta Pharma
markets.businessinsider.com - November 21 at 10:21 AM
finance.yahoo.com logoQ4 2023 Enanta Pharmaceuticals Inc Earnings Call
finance.yahoo.com - November 21 at 10:21 AM
finance.yahoo.com logoEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q4 2023 Earnings Call Transcript
finance.yahoo.com - November 21 at 10:21 AM
benzinga.com logoRecap: Enanta Pharma Q4 Earnings
benzinga.com - November 20 at 6:01 PM
finance.yahoo.com logoEnanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2023, with Webcast and Conference Call Today at 4:30 p.m. ET
finance.yahoo.com - November 20 at 6:01 PM
finance.yahoo.com logoEnanta Pharmaceuticals Inc (ENTA) Reports Fiscal Q4 and Full-Year Earnings Amid R&D Focus
finance.yahoo.com - November 20 at 6:01 PM
msn.com logoEnanta Pharma Q4 2023 Earnings Preview
msn.com - November 19 at 7:21 PM
markets.businessinsider.com logoEnanta Pharmaceuticals earnings preview: what to expect
markets.businessinsider.com - November 19 at 9:20 AM
finance.yahoo.com logoMILLENNIUM MANAGEMENT LLC Bolsters Portfolio with Enanta Pharmaceuticals Inc (ENTA) Shares
finance.yahoo.com - November 17 at 9:51 AM
morningstar.com logoEnanta Pharmaceuticals Inc ENTA
morningstar.com - November 16 at 1:22 PM
finance.yahoo.com logoEnanta Pharmaceuticals to Host Conference Call on November 20 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Full Year Ended September 30, 2023
finance.yahoo.com - November 13 at 9:12 AM
finance.yahoo.com logoAlpine Immune Sciences, Inc. (ALPN) Surges 8.9%: Is This an Indication of Further Gains?
finance.yahoo.com - October 30 at 12:24 PM
markets.businessinsider.com logoAnalyst Expectations for Enanta Pharma's Future
markets.businessinsider.com - October 23 at 12:28 PM
finance.yahoo.com logoEnanta Pharmaceuticals to Host Virtual Key Opinion Leader Event to Discuss Advances in the Treatment Landscape for Respiratory Syncytial Virus (RSV) and its Proprietary RSV Pipeline
finance.yahoo.com - October 13 at 10:14 AM
finance.yahoo.com logoShareholders in Enanta Pharmaceuticals (NASDAQ:ENTA) have lost 87%, as stock drops 12% this past week
finance.yahoo.com - October 6 at 8:21 AM
Get Enanta Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENTA and its competitors with MarketBeat's FREE daily newsletter.



ENTA Media Mentions By Week

ENTA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ENTA
News Sentiment

1.91

0.45

Average
Medical
News Sentiment

ENTA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ENTA Articles
This Week

2

2

ENTA Articles
Average Week

Get Enanta Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENTA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ENTA) was last updated on 2/23/2024 by MarketBeat.com Staff